
AstraZeneca Partners with Quell for $2 Billion Cell Therapy Development Agreement
June 9, 2023
AstraZeneca and Quell Therapeutics have entered into a significant agreement, valued at over $2 billion, to collaborate on the development of cell therapies for the treatment of autoimmune diseases. This partnership aims to create innovative treatments that could potentially provide








